The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 3, 2004, Pages 529-538

  Sijin, L ^a   Ziwei, C ^b   Yajun, L ^c   Meiyu, D ^d   Hongwei, Z ^e   Guofa, H ^a   Siguo, L ^a   Hong, G ^a   Zhihong, Z ^d   Xiaolei, L ^a   Yingyun, W ^a   Yan, X ^c   Weide, Lao ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e Beijing Haidian Hospital   (China)

Author keywords

Cancer cells; Nucleostemin; Proliferation; RNAi; Tumorigenesis

Indexed keywords

BINDING PROTEIN; NUCLEOSTEMIN; PROTEIN P53; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DNA SYNTHESIS; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MYOBLAST; NEUROEPITHELIUM; NUCLEOSTEMIN GENE; PRIORITY JOURNAL; RNA INTERFERENCE;

BLOTTING, NORTHERN; CARRIER PROTEINS; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HELA CELLS; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 8544228351     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tsai R.Y., McKay R.D.: A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes & Dev., 16(23):2991-3003, 2002.
2. Liu Sijin, Xue Yan, Lao Weide, et al.: Functional analysis of human osteopontin hOPN? n cellular proliferation. High Technology Letters 13(2):25-28, 2003.
3. Liu Sijin, Xue Yan, Lao Weide, et al.: The Effect of Human Osteopontin on the Proliferation, Transmigration and Expression of Matrix Metallproteinase-2 and 9 of Osteosarcoma Cells in Vitro. Chinese Medical Journal in press (2003).
4. KIPI during myocyte development. International Journal of Cardiology 67:133-142, 1998.
5. Sun. Y, Kim. H., Parker. M., et al.: Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness. Anticancer Res. 16(10):1-7, 1996.
6. Takagi S., Mcfadden M.L., Humphreys R.E., et al.: Detection of 5-bromo-2-deoxyuridine (BruUrd) incorporation with monoclonal anti-BruUrd antibody after deoxyribonuclease treatment. Cytometry 14:640-648, 1993.
7. Baddoo M., Hill K., Wilkinson R. et al.: Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell Biochem. 89(6):1235-1249, 2003.
8. Bernatchez R., Belkacemi L., Rassart E., et al.: Differential expression of membrane and soluble adenylyl cyclase isoforms in cytotrophoblast cells and syncytiotrophoblasts of human placenta. Placenta 24(6):648-657, 2003.
9. Chambers I., Colby D., Robertson M., et al.: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113(5):643-655, 2003.
10. Sui G., Soohoo C., Affar E.B., et al.: A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Acad. Sci. USA 99:5515-5520, 2002.
11. Yu J.Y., DeRuiter S.L. and Turner D.L.: RNA interference by expression of short interfering RNAs and hairpin in mammalian cells. Proc. Acad. Sci. USA 99:6047-6052, 2002.
12. Paul C.P., Good P.D., Winer I., et al.: Effective expression of small interfering RNA in human cells. Nature Biltechnol. 20:505-508, 2002.
13. Bernardi R., Pandolfi P.P.: The nucleolus: at the stem of immortality. Nat. Med. 9(1):24-25, 2003.
14. Nevins J.R.: Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585-593, 1998.
15. Dyson N.: The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262, 1998.
16. Harbour J.W., Dean D.C.: The Rb/E2F pathway, expanding roles and emerging paradigms. Genes Dev. 14:2393-2409, 2000.